Clinical performance of artificial intelligence-powered annotation of tumor cell PD-L1 expression for treatment of immune-checkpoint inhibitor (ICI) in advanced non-small cell lung cancer (NSCLC).

被引：2
|
作者：
Kim, Hyojin
Choi, Sangjoon
Kim, Seokhwi
Aum, Jaehong
Pereira, Sergio
Park, Seonwook
Ma, Minuk
Shin, Seunghwan
Paeng, Kyunghyun
Yoo, Donggeun
Jung, Wonkyung
Ock, Chan-Young
Lee, Se-Hoon
Chung, Jin-haeng
Choi, Yoon-La
Mok, Tony S. K.
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[3] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
[4] Lunit Inc, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Med, Seoul, South Korea
[7] Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9026
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1 expression in paired non-small cell lung cancer tumor samples
    Kim, Jhingook
    Sorensen, Steffen Filskov
    Choi, Yoon-La
    Wang, Zhen
    Sun, Jong-Mu
    Choi, Hyejoo
    Georgsen, Jeanette Baehr
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Wu, Dianna Y.
    Meldgaard, Peter
    Zhou, Wei
    Hager, Henrik
    CANCER RESEARCH, 2015, 75
  • [32] PD-L1-Gene Expression by nCounter Correlates with PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Cabrera, C.
    Aguado, C.
    Teixido, C.
    Pare, L.
    Castellvi, J.
    Lopez, L.
    Marin, E.
    Bernal, X.
    Martinez, D.
    Gimenez-Capitan, A.
    Vinolas, N.
    Yeste, Z.
    Baixeras, N.
    Roman, R.
    Molina-Vila, M.
    Reguart, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S927 - S927
  • [33] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [34] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [35] Efficacy of immune checkpoint inhibitors according to PD-L1 tumor proportion scores in non-small cell lung cancer
    Park, Seongho
    Choi, Yoo-Duk
    Kim, Jieun
    Kho, Bo-Gun
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Young-Chul
    THORACIC CANCER, 2020, 11 (02) : 408 - 414
  • [36] Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Rossi, Emanuela
    Sgambato, Assunta
    De Chiara, Giovanni
    Casaluce, Francesca
    Losanno, Tania
    Sacco, Paola Claudia
    Santabarbara, Giuseppe
    Gridelli, Cesare
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 419 - 428
  • [37] Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
    Manglaviti, Sara
    Brambilla, Marta
    Signorelli, Diego
    Ferrara, Roberto
    Lo Russo, Giuseppe
    Proto, Claudia
    Galli, Giulia
    De Toma, Alessandro
    Occhipinti, Mario
    Viscardi, Giuseppe
    Beninato, Teresa
    Zattarin, Emma
    Bini, Marta
    Lobefaro, Riccardo
    Massa, Giacomo
    Bottiglieri, Achille
    Apollonio, Giulia
    Sottotetti, Elisa
    Di Mauro, Rosa Maria
    Trevisan, Benedetta
    Ganzinelli, Monica
    Fabbri, Alessandra
    de Braud, Filippo G. M.
    Garassino, Marina Chiara
    Prelaj, Arsela
    CLINICAL LUNG CANCER, 2022, 23 (01) : E17 - E28
  • [38] PD-L1 Expression in Circulating Tumor Cells and Response to PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer Patients
    Guibert, N.
    Delaunay, M.
    Boubekeur, N.
    Rouquette, I.
    Lusque, A.
    Clermont, E.
    Fortoul, A.
    Farella, M.
    Favre, G.
    Pradines, A.
    Mazieres, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1997 - S1997
  • [39] Exosomal PD-L1 expression as non-invasive biomarker for immune checkpoint inhibitors in non-small cell lung cancer
    Gunasekaran, Muthukumar
    Russo, Alessandro
    Cardona, Andres F.
    Perez, Diego de Miguel
    Lapidus, Rena
    Cooper, Brandon
    Kaushal, Sunjay
    Adamo, Vincenzo
    Rolfo, Christian
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [40] Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression
    Leonetti, Alessandro
    Giudice, Giulia C.
    Perrone, Fabiana
    Tiseo, Marcello
    Giovannetti, Elisa
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 520 - 522
12345